Characteristic | Postoperative complications | Wald | P | OR | 95% CI | |
---|---|---|---|---|---|---|
NO(n = 252) | YES(n = 86) | |||||
Sexuality/case |  |  | 14.83 | <0.001 | 2.794 | (1.656–4.712) |
female | 138 | 26 | Â | Â | Â | Â |
male | 114 | 60 | Â | Â | Â | Â |
age/case |  |  | 2.427 | 0.119 | 1.48 | (0.904–2.424) |
≤ 57y | 133 | 37 |  |  |  |  |
>57y | 119 | 49 | Â | Â | Â | Â |
BSA/case |  |  | 0.996 | 0.318 | 1.284 | (0.786–2.099) |
≤ 1.64m2 | 130 | 39 |  |  |  |  |
>1.64m2 | 122 | 47 | Â | Â | Â | Â |
smoking history/case |  |  | 14.21 | <0.001 | 2.619 | (1.587–4.32) |
no | 170 | 38 | Â | Â | Â | Â |
yes | 82 | 48 | Â | Â | Â | Â |
chronic alcohol consumption /case |  |  | 6.333 | 0.12 | 1.934 | (1.157–3.233) |
no | 186 | 51 | Â | Â | Â | Â |
yes | 66 | 35 | Â | Â | Â | Â |
hypertension/case |  |  | 4.818 | 0.028 | 1.885 | (1.070–3.321) |
no | 207 | 61 | Â | Â | Â | Â |
yes | 45 | 25 | Â | Â | Â | Â |
FEVI/case |  |  | 6.854 | 0.009 | 0.511 | (0.309–0.845) |
≤ 2.00 | 75 | 39 |  |  |  |  |
>2.00 | 177 | 47 | Â | Â | Â | Â |
FEV1 Pre / Ref |  |  | 8.792 | 0.003 | 0.466 | (0.281–0.772) |
/case | Â | Â | Â | Â | Â | Â |
≤ 92% | 114 | 55 |  |  |  |  |
>92% | 138 | 31 | Â | Â | Â | Â |
FEV1/FVC%/case |  |  | 3.036 | 0.081 | 0.644 | (0.393–1.056) |
≤ 86.81% | 119 | 50 |  |  |  |  |
>86.81% | 133 | 36 | Â | Â | Â | Â |
tumor diameter/case |  |  | 11.12 | 0.001 | 2.366 | (1.426–3.924) |
≤ 2.10 | 129 | 28 |  |  |  |  |
>2.10 | 123 | 58 | Â | Â | Â | Â |
tumor composition/case |  | 5.244 | 0.022 | 1.798 | (1.088–2.971) | |
ground-glass | 130 | 32 | Â | Â | Â | Â |
solid | 122 | 54 | Â | Â | Â | Â |
tumor type/case |  |  | 4.749 | 0.029 | 2.022 | (1.073–3.808) |
AD | 221 | 67 | Â | Â | Â | Â |
non-AD | 31 | 19 | Â | Â | Â | Â |
T stage/case |  |  | 13.59 | <0.001 | 2.571 | (1.556–4.247) |
0–1 | 158 | 34 |  |  |  |  |
≥ 2 | 94 | 52 |  |  |  |  |
N stage/case |  |  | 8.63 | 0.003 | 2.767 | (1.403–5.458) |
0 | 230 | 68 | Â | Â | Â | Â |
1,2 | 22 | 18 | Â | Â | Â | Â |
clinical staging /case | Â | Â | 13.8 | <0.001 | 2.522 | (1.600-4.569) |
MIS-I | 199 | 50 | Â | Â | Â | Â |
II-III | 53 | 36 | Â | Â | Â | Â |
operation time |  |  | 3.976 | 0.046 | 1.655 | (1.009–2.714) |
≤ 112 | 137 | 36 |  |  |  |  |
>112 | 115 | 50 | Â | Â | Â | Â |
number of lymph nodes /case |  | 9.538 | 0.002 | 2.218 | (1.338–3.676) | |
≤ 10 | 140 | 31 |  |  |  |  |
>10 | 112 | 55 | Â | Â | Â | Â |